Literature DB >> 6963061

Preservative-related problems in soft contact lens wearers.

P Wright, I Mackie.   

Abstract

Details of 61 patients are presented who, having worn soft contact lenses for many months, developed red eyes, conjunctival irritation with minimal discharge, and progressive loss of tolerance of the lenses. Investigations revealed an absence of infective agents and the clinical course after treatment with preservative-free solutions strongly suggested that preservatives, especially organic mercurials, were responsible for the changes. The corneal signs were slow to clear but after resolution the majority of patients were able to return to soft contact lens wear using a heat disinfection system with preservative-free solutions. Skin testing to a wide range of substances, including preservatives, contact lens solutions, and common sensitizers, revealed only one responder to Thiomersal out of 21 tested. However a rapid response followed conjunctival challenge with 0.005 per cent Thiomersal in normal saline in all subjects tested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6963061

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  4 in total

1.  The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.

Authors:  Fiona Stapleton; Carl Marfurt; Blanka Golebiowski; Mark Rosenblatt; David Bereiter; Carolyn Begley; Darlene Dartt; Juana Gallar; Carlos Belmonte; Pedram Hamrah; Mark Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-18       Impact factor: 4.799

Review 2.  Vaccines without thiomersal: why so necessary, why so long coming?

Authors:  A J van't Veen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Tear film, contact lens, and patient factors associated with corneal staining.

Authors:  Jason J Nichols; Loraine T Sinnott
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

4.  Contact lenses for infant aphakia.

Authors:  L G Amaya; L Speedwell; D Taylor
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.